Combining Medications With Bariatric Surgery to Treat ObesityCombining Medications With Bariatric Surgery to Treat Obesity
This JAMA Insights examines the efficacy, adverse effects, and best approach to combining metabolic and bariatric surgery with weight loss medications for the treatment of obesity.
What to know about breast self-awareness and how it fits into cancer preventionWhat to know about breast self-awareness and how it fits into cancer prevention

What does it mean to have breast self-awareness?
Menopause Hormone Therapy May Boost GLP-1 Drug BenefitsMenopause Hormone Therapy May Boost GLP-1 Drug Benefits

(MedPage Today) — Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. Among 120 women with overweight or obesity… (MedPage Today) — Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they Read More
The 5 Worst Things You Can Do While Taking a GLP-1 for Weight LossThe 5 Worst Things You Can Do While Taking a GLP-1 for Weight Loss

According to doctors, making a misstep is easier than you may think. According to doctors, making a misstep is easier than you may think.
STAT+: Launch of Wegovy pill looks to be going strong so farSTAT+: Launch of Wegovy pill looks to be going strong so far

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it’s still early, but Novo Nordisk already appears to be having a robust rollout of the Wegovy pill. Read More
Ozempic boom collides with America’s eating habits as restaurants shrink portionsOzempic boom collides with America’s eating habits as restaurants shrink portions

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and Zepbound go mainstream, restaurants are responding to customers with smaller appetites — and a growing appetite for protein-packed meals. “People on GLP-1s are prioritizing protein because it’s the macronutrient that Read More
As GLP-1s become more available, some who aren’t overweight may consider using themAs GLP-1s become more available, some who aren’t overweight may consider using them
As GLP-1 drugs become more available, some people might use them despite not having excess weight. As GLP-1 drugs become more available, some people might use them despite not having excess weight.
Consumer Food Purchases After GLP-1 RA InitiationConsumer Food Purchases After GLP-1 RA Initiation
This cross-sectional study examines whether initiating glucagon-like peptide-1 receptor agonists (GLP-1RAs) for treatment is associated with changes in the nutritional quality and processing level of supermarket purchases. This cross-sectional study examines whether initiating glucagon-like peptide-1 receptor agonists (GLP-1RAs) for treatment is associated with changes in the nutritional quality and processing level of supermarket purchases.
GLP-1 Therapy May Offer Added Benefit in IBD Beyond Weight LossGLP-1 Therapy May Offer Added Benefit in IBD Beyond Weight Loss

(MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two poster presentations at the Crohn’s & Colitis Congress. In a large… (MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend Read More
Why I’m Choosing Not to Take GLP-1s, Even Though Everyone Expects Me ToWhy I’m Choosing Not to Take GLP-1s, Even Though Everyone Expects Me To

I’m a candidate for the meds, but they’re not for me—at least for now. I’m a candidate for the meds, but they’re not for me—at least for now.